MedTrace Logo

Patient Preference Comparison of AZARGA Versus COSOPT

NCT01340014 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2014-02-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to assess patient preference regarding ocular comfort of AZARGA® compared to COSOPT® after one week instillation of each study medication.

Conditions

Interventions

DRUG

Brinzolamide 1.0% + Timolol 0.5% ophthalmic suspension

DRUG

Dorzolamide 2.0% + Timolol 0.5% ophthalmic solution

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Severine Durier, Pharm.D · Alcon Global Medical Affairs, Europe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-10-31
Completion
2012-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01340014 on ClinicalTrials.gov